# NYSTATIN AND TRIAMCINOLONE ACETONIDE
> **ANDA210077** · Abbreviated New Drug Application (Generic) · Sponsor: STRIDES PHARMA · Approved 2018-01-29
## Drug
- **FDA Application Number:** ANDA210077
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NYSTATIN AND TRIAMCINOLONE ACETONIDE
- **Generic name:** Nystatin
- **Active ingredients:** NYSTATIN; TRIAMCINOLONE ACETONIDE
- **Dosage form:** OINTMENT
- **Route:** TOPICAL
- **Marketing status:** Discontinued
- **Sponsor:** STRIDES PHARMA
- **First approval:** 2018-01-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210077)
---
*MORVS · CC0 1.0*